Giulia Zappalà
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Giulia Zappalà has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Anja Boisen
4 shared publicationsElodie Dumont
3 shared publicationsTomas Rindzevicius
The Danish National Research Foundation and Villum Foundation's Center for Intelligent Drug Delivery and Sensing Using Microcontainers and Nanomechanics (IDUN), Department of Health Technology, Technical University of Denmark, Denmark
2 shared publications- AmirAli Abbaspourmani
National Centre for Nano Fabrication and Characterization (DTU Nanolab), Technical University of Denmark, Ørsteds Plads, Lyngby, 2800, DENMARK
1 shared publication Amirali Abbaspourmani
Silmeco ApS, 2450, Copenhagen, Denmark
1 shared publication- Anette Müllertz
Department of Pharmacy, University of Copenhagen, Universitetsparken 2, Copenhagen 2100, Denmark; Bioneer A/S, Kogle Allé 2, Hørsholm 2970, Denmark
1 shared publication
Latest Publications
- Open Access
- 7 April 2025
- Published by Elsevier in Surfaces and Interfaces
- Vol. 64
Atomic layer deposition of hafnium dioxide for increasing temporal stability of silver-capped silicon nanopillar substrates used for SERS
- 7 April 2025
- Published by Elsevier in Surfaces and Interfaces
- Vol. 64
Open AccessAtomic layer deposition of hafnium dioxide for increasing temporal stability of silver-capped silicon nanopillar substrates used for SERS
- 8 August 2023
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 148 (19) , 4787-4798
Nitroaromatic explosives’ detection and quantification using an attention-based transformer on surface-enhanced Raman spectroscopy maps
Rapidly and accurately detecting and quantifying the concentrations of nitroaromatic explosives is critical for public health and security.
- 8 August 2023
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 148 (19) , 4787-4798
Nitroaromatic explosives’ detection and quantification using an attention-based transformer on surface-enhanced Raman spectroscopy maps
Rapidly and accurately detecting and quantifying the concentrations of nitroaromatic explosives is critical for public health and security.
- 7 February 2023
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 23 (6) , 1603-1612
Moving perfusion culture and live-cell imaging from lab to disc: proof of concept toxicity assay with AI-based image analysis
In vitro, cell-based assays are essential in diagnostics and drug development. There are ongoing efforts to establish new technologies that enable real-time detection of cell–drug interaction during culture under flow conditions. Our compact (10 × 10 × 8.5 cm) cell culture and microscope on disc (CMoD) platform aims to decrease the application barriers of existing lab-on-a-chip (LoC) approaches. For the first time in a centrifugal device, (i) cells were cultured for up to six days while a spindle motor facilitated culture medium perfusion, and (ii) an onboard microscope enabled live bright-field imaging of cells while the data wirelessly transmitted to a computer. The quantification of cells from the acquired images was done using artificial intelligence (AI) software. After optimization, the obtained cell viability data from the AI-based image analysis proved to correlate well with data collected from commonly used image analysis software. The CMoD was also suitable for conducting a proof-of-concept toxicity assay with HeLa cells under continuous flow. The half-maximal inhibitory time (IT50) for various concentrations of doxorubicin (DOX) in the case of HeLa cells in flow, was shown to be lower than the IT50 obtained from a static cytotoxicity assay, indicating a faster onset of cell death in flow. The CMoD proved to be easy to handle, enabled cell culture and monitoring without assistance, and is a promising tool for examining the dynamic processes of cells in real-time assays.
- 7 February 2023
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 23 (6) , 1603-1612
Moving perfusion culture and live-cell imaging from lab to disc: proof of concept toxicity assay with AI-based image analysis
In vitro, cell-based assays are essential in diagnostics and drug development. There are ongoing efforts to establish new technologies that enable real-time detection of cell–drug interaction during culture under flow conditions. Our compact (10 × 10 × 8.5 cm) cell culture and microscope on disc (CMoD) platform aims to decrease the application barriers of existing lab-on-a-chip (LoC) approaches. For the first time in a centrifugal device, (i) cells were cultured for up to six days while a spindle motor facilitated culture medium perfusion, and (ii) an onboard microscope enabled live bright-field imaging of cells while the data wirelessly transmitted to a computer. The quantification of cells from the acquired images was done using artificial intelligence (AI) software. After optimization, the obtained cell viability data from the AI-based image analysis proved to correlate well with data collected from commonly used image analysis software. The CMoD was also suitable for conducting a proof-of-concept toxicity assay with HeLa cells under continuous flow. The half-maximal inhibitory time (IT50) for various concentrations of doxorubicin (DOX) in the case of HeLa cells in flow, was shown to be lower than the IT50 obtained from a static cytotoxicity assay, indicating a faster onset of cell death in flow. The CMoD proved to be easy to handle, enabled cell culture and monitoring without assistance, and is a promising tool for examining the dynamic processes of cells in real-time assays.